| 12091425 |
Compounds that inhibit MCL-1 protein |
David Karl Bedke, Michael W. Gribble, Jr., Michael G. Johnson, Kexue Li |
2024-09-17 |
$478,697,000 |
| 11306107 |
Compounds that inhibit MCL-1 protein |
Sean P. Brown, David Karl Bedke, Michael R. DeGraffenreid, Jiasheng Fu, Zhihong Li +23 more |
2022-04-19 |
$184,680,000 |
| 11224601 |
Compounds that inhibits MCL-1 protein |
Paul E. Harrington, Kate Ashton, Sean P. Brown, Matthew R. Kaller, Brian Alan LANMAN +7 more |
2022-01-18 |
$641,433,000 |
| 10821115 |
Compounds that inhibit Mcl-1 protein |
Paul E. Harrington, Kate Ashton, Sean P. Brown, Matthew R. Kaller, Brian Alan LANMAN +7 more |
2020-11-03 |
$280,862,000 |
| 10632128 |
Compounds that inhibit Mcl-1 protein |
Paul E. Harrington, Kate Ashton, Sean P. Brown, Matthew R. Kaller, Brian Alan LANMAN +7 more |
2020-04-28 |
$393,385,000 |
| 8940724 |
Quinoline derivitives and their uses |
Timothy D. Cushing, Paul John Dransfield, Felix Gonzalez Lopez De Turiso, Michael G. Johnson, Vatee Pattaropong +1 more |
2015-01-27 |
$279,618,000 |
| 8765940 |
Heterocyclic compounds and their uses |
Matthew Brown, Yi Chen, Timothy D. Cushing, Felix Gonzalez Lopez De Turiso, Xiao He +5 more |
2014-07-01 |
$165,638,000 |
| 8450522 |
Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
Sean P. Brown, Paul John Dransfield, Jonathan Houze, Jiwen Liu, Julio C. Medina +6 more |
2013-05-28 |
$360,303,000 |
| 8030354 |
Substituted biphenyl GPR40 modulators |
Sean P. Brown, Qiong Cao, Paul John Dransfield, Xiaohui Du, Zice Fu +22 more |
2011-10-04 |
$40,772,000 |
| 8003648 |
Heterocyclic GPR40 modulators |
Hilary Plake Beck, Paul John Dransfield, Zice Fu, Jonathan Houze, XianYun Jiao +11 more |
2011-08-23 |
$69,276,000 |
| 7745438 |
3-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitors |
Howard Barff Broughton, Robert Dally, Timothy Barrett Durham, Maria Rosario Gonzalez-Garcia, Patric James Hahn +5 more |
2010-06-29 |
$59,946,000 |
| 7714008 |
Heterocyclic GPR40 modulators |
Hilary Plake Beck, Paul John Dransfield, Zice Fu, Jonathan Houze, XianYun Jiao +11 more |
2010-05-11 |
$337,600,000 |
| 7572934 |
Substituted biphenyl GPR40 modulators |
Sean P. Brown, Paul John Dransfield, Zice Fu, Jonathan Houze, Xian Yun Jiao +3 more |
2009-08-11 |
$290,351,000 |
| 7144898 |
Indole derivatives for the treatment of depression and anxiety |
Marvin M. Hansen, John Xiaoqiang He, Nicholas Allan Honigschmidt, Daniel James Koch, Vincent Patrick Rocco +2 more |
2006-12-05 |
$65,374,000 |
| 6844344 |
Benzofuran derivatives |
John Xiaoqiang He, Nicholas Allan Honigschmidt, Vincent Patrick Rocco, Patrick Gianpietro Spinazze, Kumiko Takeuchi |
2005-01-18 |
$148,156,000 |
| 6835733 |
Tropane linked benzofuran derivatives |
John Xiaoqiang He, Nicholas Allan Honigschmidt, Vincent Patrick Rocco, Patrick Gianpietro Spinazze, Kumiko Takeuchi |
2004-12-28 |
$151,621,000 |
| 6784180 |
Piperidines derivatives and their use as serotonin receptor antagonists |
John Xiaoqiang He, Nicholas Allan Honigschmidt, Vincent Patrick Rocco, Patrick Gianpietro Spinazze, Kumiko Takeuchi |
2004-08-31 |
$188,799,000 |
| 6251921 |
Antithrombotic diamines |
Jolie Anne Bastian, Nickolay Y Chirgadze, Michael Lyle Denney, Matthew Joseph Fisher, Robert J. Foglesong +13 more |
2001-06-26 |
$203,013,000 |
| 6025382 |
Antithrombotic diamines |
Jolie Anne Bastian, Nickolay Y Chirgadze, Michael Lyle Denney, Matthew Joseph Fisher, Robert J. Foglesong +13 more |
2000-02-15 |
$61,885,000 |
